These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 34375393)

  • 21. Dutasteride reduces prostate size and prostate specific antigen in older hypogonadal men with benign prostatic hyperplasia undergoing testosterone replacement therapy.
    Page ST; Hirano L; Gilchriest J; Dighe M; Amory JK; Marck BT; Matsumoto AM
    J Urol; 2011 Jul; 186(1):191-7. PubMed ID: 21575967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone.
    Budoff MJ; Ellenberg SS; Lewis CE; Mohler ER; Wenger NK; Bhasin S; Barrett-Connor E; Swerdloff RS; Stephens-Shields A; Cauley JA; Crandall JP; Cunningham GR; Ensrud KE; Gill TM; Matsumoto AM; Molitch ME; Nakanishi R; Nezarat N; Matsumoto S; Hou X; Basaria S; Diem SJ; Wang C; Cifelli D; Snyder PJ
    JAMA; 2017 Feb; 317(7):708-716. PubMed ID: 28241355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testosterone replacement therapy of opioid-induced male hypogonadism improved body composition but not pain perception: a double-blind, randomized, and placebo-controlled trial.
    Glintborg D; Vaegter HB; Christensen LL; Bendix E; Graven-Nielsen T; Andersen PG; Andersen M
    Eur J Endocrinol; 2020 Jun; 182(6):539-548. PubMed ID: 32213659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-Term Testosterone Supplementation in Older Men Attenuates Age-Related Decline in Aerobic Capacity.
    Traustadóttir T; Harman SM; Tsitouras P; Pencina KM; Li Z; Travison TG; Eder R; Miciek R; McKinnon J; Woodbury E; Basaria S; Bhasin S; Storer TW
    J Clin Endocrinol Metab; 2018 Aug; 103(8):2861-2869. PubMed ID: 29846604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management.
    Grossmann M; Matsumoto AM
    J Clin Endocrinol Metab; 2017 Mar; 102(3):1067-1075. PubMed ID: 28359097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MANAGEMENT OF ENDOCRINE DISEASE: Rationale and current evidence for testosterone therapy in the management of obesity and its complications.
    Lapauw B; Kaufman JM
    Eur J Endocrinol; 2020 Dec; 183(6):R167-R183. PubMed ID: 33105105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial.
    Wittert G; Bracken K; Robledo KP; Grossmann M; Yeap BB; Handelsman DJ; Stuckey B; Conway A; Inder W; McLachlan R; Allan C; Jesudason D; Fui MNT; Hague W; Jenkins A; Daniel M; Gebski V; Keech A
    Lancet Diabetes Endocrinol; 2021 Jan; 9(1):32-45. PubMed ID: 33338415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Testosterone supplementation therapy for older men: potential benefits and risks.
    Gruenewald DA; Matsumoto AM
    J Am Geriatr Soc; 2003 Jan; 51(1):101-15; discussion 115. PubMed ID: 12534854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive effects of testosterone and finasteride administration in older hypogonadal men.
    Borst SE; Yarrow JF; Fernandez C; Conover CF; Ye F; Meuleman JR; Morrow M; Zou B; Shuster JJ
    Clin Interv Aging; 2014; 9():1327-33. PubMed ID: 25143719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term testosterone therapy in type 2 diabetes is associated with reduced mortality without improvement in conventional cardiovascular risk factors.
    Hackett G; Cole N; Mulay A; Strange RC; Ramachandran S
    BJU Int; 2019 Mar; 123(3):519-529. PubMed ID: 30216622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early weight loss predicts the reduction of obesity in men with erectile dysfunction and hypogonadism undergoing long-term testosterone replacement therapy.
    Salman M; Yassin DJ; Shoukfeh H; Nettleship JE; Yassin A
    Aging Male; 2017 Mar; 20(1):45-48. PubMed ID: 28084147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I-III: observational data from two registry studies.
    Saad F; Yassin A; Doros G; Haider A
    Int J Obes (Lond); 2016 Jan; 40(1):162-70. PubMed ID: 26219417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome.
    Giltay EJ; Tishova YA; Mskhalaya GJ; Gooren LJ; Saad F; Kalinchenko SY
    J Sex Med; 2010 Jul; 7(7):2572-82. PubMed ID: 20524974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testosterone administration in older men.
    Matsumoto AM
    Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Testosterone Replacement on Electrocardiographic Parameters in Men: Findings From Two Randomized Trials.
    Gagliano-Jucá T; Içli TB; Pencina KM; Li Z; Tapper J; Huang G; Travison TG; Tsitouras P; Harman SM; Storer TW; Bhasin S; Basaria S
    J Clin Endocrinol Metab; 2017 May; 102(5):1478-1485. PubMed ID: 27992261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reflections on the T Trials.
    Swerdloff R; Wang C
    Andrology; 2020 Nov; 8(6):1512-1518. PubMed ID: 32902162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Comparison of Secondary Polycythemia in Hypogonadal Men Treated with Clomiphene Citrate versus Testosterone Replacement: A Multi-Institutional Study.
    Wheeler KM; Smith RP; Kumar RA; Setia S; Costabile RA; Kavoussi PK
    J Urol; 2017 Apr; 197(4):1127-1131. PubMed ID: 27984109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters.
    Yassin A; Nettleship JE; Talib RA; Almehmadi Y; Doros G
    Aging Male; 2016; 19(1):64-9. PubMed ID: 26742589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LH and non-SHBG testosterone and estradiol levels during testosterone replacement of hypogonadal men: further evidence that steroid negative feedback increases as men grow older.
    Winters SJ; Wang C;
    J Androl; 2010; 31(3):281-7. PubMed ID: 19959827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes.
    Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P
    J Sex Med; 2013 Jun; 10(6):1612-27. PubMed ID: 23551886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.